MedLumics

MedLumics

Madrid, Spain· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $23M

Overview

MedLumics is a private, clinical-stage medical device company pioneering photonics-based solutions for minimally invasive surgery, initially targeting ophthalmology. Its core technology integrates optics, sensing, and real-time data to enhance precision and outcomes in procedures like retinal surgery. The company is likely pre-revenue, advancing its lead program through clinical validation. Key challenges include technical execution, regulatory pathways, and competition in the specialized ophthalmic surgical device market.

Ophthalmology

Technology Platform

Integrated photonics platform combining micro-optics, real-time sensing (e.g., OCT), and software for precision guidance and control in minimally invasive surgical catheters.

Funding History

2
Total raised:$23M
Series B$15M
Series A$8M

Opportunities

The global shift towards minimally invasive surgery and an aging population driving ophthalmic procedure volumes create a strong tailwind.
The platform technology allows for expansion beyond ophthalmology into neurology, cardiology, and ENT, offering significant long-term growth potential.

Risk Factors

High technical and clinical validation risk for a novel device class.
Facing intense competition from large, entrenched medical device companies with dominant market access.
Regulatory approval and securing favorable reimbursement are critical, uncertain, and lengthy processes.

Competitive Landscape

Competes in the ophthalmic surgical device segment against giants like Alcon (Novartis), Johnson & Johnson Vision, and Bausch + Lomb, as well as specialized players like Dutch Ophthalmic Research Center (DORC). Differentiation relies on superior real-time imaging and guidance capabilities, a niche not fully addressed by current laser or visualization systems.